Cantab Pharmaceuticals, a British biotechnology firm, has a genetically engineered vaccine now in clinical trials to protect against herpes simplex infection and reduce the recurrence of genital herpes.

ECONOMIST: Vaccines

This BMC Infectious Diseases paper cited by Wolf showed that mice instilled with various vaginal gels containing microbicide experienced greater herpes simplex-2 infections when challenged three days later.

FORBES: Sex Safety and Personal Lubricants

The Herpes simplex virus, for example, infects 80% of adults.

ECONOMIST: Genetics and infectious disease: The germ of an idea | The

The Centers for Disease Control and Prevention (CDC) estimates that about 1 in 6 Americans (16.2 percent) between 14 and 49 are infected with herpes simplex virus type 2.

FORBES: For Many, Herpes May Cause Memory Loss Along with Cold Sores

New research suggests that people exposed to the herpes simplex type 1 virus, the virus that causes cold sores, may be at greater risk for developing cognitive problems, particularly memory problems.

FORBES: For Many, Herpes May Cause Memory Loss Along with Cold Sores

An estimated 16% of U.S. adults are infected with herpes simplex virus type 2 (HSV-2), which can cause bumps, blisters, or sores on the genitals and surrounding areas, along with pain and itching.

CNN: Symptom-free herpes contagious 10% of the time

On the bright side, researchers at Albert Einstein College of Medicine of Yeshiva University have discovered a strategy for preventing infections due to herpes simplex viruses (herpes simplex virus 2, the virus that causes genital herpes, and herpes simplex virus 1).

FORBES: For Many, Herpes May Cause Memory Loss Along with Cold Sores